Guardant Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers the results of the Annual Meeting of Stockholders held on June 18, 2025. The filing details the voting outcomes for director elections, auditor ratification, and executive compensation advisory votes.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
All three proposals presented at the Annual Meeting were approved by stockholders.
- Proposal 1 (Director Elections): All nominees were elected. Vijaya Gadde, Roberto Mignone, and Myrtle Potter received significant majority support. Musa Tariq received 70,290,715 votes for, with 28,283,766 votes withheld.
- Proposal 2 (Auditor Ratification): The selection of Deloitte & Touche LLP as the independent registered public accounting firm for the year ending December 31, 2025, was approved with 105,585,947 votes for and 24,506 votes against.
- Proposal 3 (Executive Compensation): The advisory vote to approve named executive officer compensation was approved with 91,189,702 votes for and 7,020,245 votes against.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Verify the total number of shares outstanding to contextualize the voting percentages.
- Review the Definitive Proxy Statement (Schedule 14A) filed on April 29, 2025, for detailed biographies of the elected directors and the rationale for the executive compensation plan.
- Confirm the specific terms of the engagement with Deloitte & Touche LLP for the 2025 fiscal year.